Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of High-dose Liposomal Amphotericin B (10 mg/kg) for Disseminated Histoplasmosis in AIDS: a Randomized Phase III Trial (INDUCTION Trial)

NCT05814432 is registered in ClinicalTrials.gov with Federal University of Health Science of Porto Alegre as lead sponsor.

NCT NCT05814432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05814432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of High-dose Liposomal Amphotericin B (10 mg/kg) for Disseminated Histoplasmosis in AIDS: a Randomized Phase III Trial (INDUCTION Trial)
Lead sponsor
Federal University of Health Science of Porto Alegre
Phase
Phase 3
Overall status
Recruiting
Start date
January 16, 2025
Completion date
July 1, 2032
Enrollment
279 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aids and infections, disseminated histoplasma capsulatum infection, fungal infection, immunosuppression